Latest filings (excl ownership)
25-NSE
Exchange delisting
27 Oct 22
6-K
Molecular Data Receives De-Listing Notice from NASDAQ
27 May 22
6-K
Molecular Data Inc. Announces ADS Ratio Change
20 May 22
6-K
Molecular Data Inc. Announces Receipt of Nasdaq Non-Compliance Letter
19 May 22
F-6EF
Automatic registration for ADRs (foreign)
13 May 22
NT 20-F
Notice of late annual filing (foreign)
2 May 22
6-K
Current report (foreign)
30 Nov 21
6-K
Current report (foreign)
26 Nov 21
6-K
Current report (foreign)
1 Oct 21
6-K
Molecular Data Inc. Prices $15 Million Registered Direct Offering
17 Sep 21
424B5
Prospectus supplement for primary offering
17 Sep 21
6-K
Current report (foreign)
13 Sep 21
424B5
Prospectus supplement for primary offering
13 Sep 21
424B7
Prospectus with selling stockholder info
26 Jul 21
6-K
Securities Purchase Agreement
14 Jul 21
424B5
Prospectus supplement for primary offering
14 Jul 21
424B5
Prospectus supplement for primary offering
12 Jul 21
EFFECT
Notice of effectiveness
24 Jun 21
20-F/A
2020 FY
Annual report (foreign) (amended)
21 Jun 21
CORRESP
Correspondence with SEC
21 Jun 21
F-3/A
Shelf registration (foreign) (amended)
11 Jun 21
CORRESP
Correspondence with SEC
11 Jun 21
UPLOAD
Letter from SEC
2 Jun 21
6-K
Current report (foreign)
27 May 21
F-3
Shelf registration (foreign)
25 May 21
6-K
Equity Purchase Agreement
24 May 21
6-K
Current report (foreign)
17 May 21
20-F
2020 FY
Annual report (foreign)
17 May 21
6-K
Current report (foreign)
14 May 21
6-K
Current report (foreign)
14 May 21
NT 20-F
Notice of late annual filing (foreign)
3 May 21
6-K
Securities Purchase Agreement
13 Apr 21
6-K
Current report (foreign)
9 Apr 21
6-K
Molecular Data announces additional disclosures for half year 2020 results
31 Mar 21
6-K
Registration Rights Agreement
4 Mar 21
6-K
Current report (foreign)
3 Mar 21
6-K
Molecular Data Inc. Announces First Half 2020 Management Financial Results
31 Dec 20
6-K
Current report (foreign)
29 Dec 20
6-K
Molecular Data Inc. Announces Changes of Chief Financial Officer
2 Dec 20
D
$5M in equity / debt / securities to be acquired, sold $3M, 1 investor
26 Oct 20
Latest ownership filings
SC 13G
TB Alternative Assets Ltd.
5 Feb 24
SC 13G/A
Streeterville Capital LLC
5 Oct 23
SC 13G/A
TB Alternative Assets Ltd.
9 Feb 23
SC 13G
TB Alternative Assets Ltd.
8 Feb 23
SC 13G/A
Streeterville Capital LLC
17 Aug 22
SC 13G/A
SHEN NEIL NANPENG
14 Feb 22
SC 13G
TB Alternative Assets Ltd.
11 Feb 22
SC 13G
TB Alternative Assets Ltd.
11 Feb 22
SC 13G
Hudson Bay Capital Management LP
7 Feb 22
SC 13G
Innovation Works Development Fund II, L.P.
28 Apr 21
SC 13G
Streeterville Capital LLC
15 Apr 21
SC 13G
TB Alternative Assets Ltd.
16 Feb 21
SC 13G
TB Alternative Assets Ltd.
16 Feb 21
SC 13G/A
SHEN NEIL NANPENG
16 Feb 21
SC 13G
Tianfeng Huiying (Wuhan) Investment Management Co., Ltd.
5 Feb 21
SC 13G/A
Fosun International Ltd
13 Jan 21
SC 13G
Fosun International Ltd
10 Jul 20
SC 13G
Molecular Data Inc.
14 Feb 20
SC 13G
Molecular Data Inc.
13 Feb 20
SC 13G
Molecular Data Inc.
11 Feb 20